362 related articles for article (PubMed ID: 31470785)
21. Cross talk between Leishmania donovani CpG DNA and Toll-like receptor 9: an immunoinformatics approach.
Gupta CL; Akhtar S; Waye A; Pandey NR; Pathak N; Bajpai P
Biochem Biophys Res Commun; 2015 Apr; 459(3):424-9. PubMed ID: 25735984
[TBL] [Abstract][Full Text] [Related]
22. Oligodeoxynucleotides lacking CpG dinucleotides mediate Toll-like receptor 9 dependent T helper type 2 biased immune stimulation.
Vollmer J; Weeratna RD; Jurk M; Samulowitz U; McCluskie MJ; Payette P; Davis HL; Schetter C; Krieg AM
Immunology; 2004 Oct; 113(2):212-23. PubMed ID: 15379982
[TBL] [Abstract][Full Text] [Related]
23. CpG ODNs treatments of HIV-1 infected patients may cause the decline of transmission in high risk populations - a review, hypothesis and implications.
Becker Y
Virus Genes; 2005 Mar; 30(2):251-66. PubMed ID: 15744581
[TBL] [Abstract][Full Text] [Related]
24. Bovine toll-like receptor 9: a comparative analysis of molecular structure, function and expression.
Griebel PJ; Brownlie R; Manuja A; Nichani A; Mookherjee N; Popowych Y; Mutwiri G; Hecker R; Babiuk LA
Vet Immunol Immunopathol; 2005 Oct; 108(1-2):11-6. PubMed ID: 16098606
[TBL] [Abstract][Full Text] [Related]
25. Competition by inhibitory oligonucleotides prevents binding of CpG to C-terminal TLR9.
Avalos AM; Ploegh HL
Eur J Immunol; 2011 Oct; 41(10):2820-7. PubMed ID: 21766476
[TBL] [Abstract][Full Text] [Related]
26. The discovery of potent immunostimulatory CpG-ODNs widely distributed in bacterial genomes.
Liu J; Wei Y; Lu Y; Li Y; Chen Q; Li Y
J Microbiol; 2020 Feb; 58(2):153-162. PubMed ID: 31872374
[TBL] [Abstract][Full Text] [Related]
27. Common human Toll-like receptor 9 polymorphisms and haplotypes: association with atopy and functional relevance.
Berghöfer B; Frommer T; König IR; Ziegler A; Chakraborty T; Bein G; Hackstein H
Clin Exp Allergy; 2005 Sep; 35(9):1147-54. PubMed ID: 16164440
[TBL] [Abstract][Full Text] [Related]
28. Toll-like receptor 9 mediates CpG-DNA signaling.
Chuang TH; Lee J; Kline L; Mathison JC; Ulevitch RJ
J Leukoc Biol; 2002 Mar; 71(3):538-44. PubMed ID: 11867692
[TBL] [Abstract][Full Text] [Related]
29. DNA motifs suppressing TLR9 responses.
Trieu A; Roberts TL; Dunn JA; Sweet MJ; Stacey KJ
Crit Rev Immunol; 2006; 26(6):527-44. PubMed ID: 17341193
[TBL] [Abstract][Full Text] [Related]
30. Development of CpG-oligodeoxynucleotides for effective activation of rabbit TLR9 mediated immune responses.
Chuang TH; Lai CY; Tseng PH; Yuan CJ; Hsu LC
PLoS One; 2014; 9(9):e108808. PubMed ID: 25269083
[TBL] [Abstract][Full Text] [Related]
31. Proinflammatory Stimulation of Toll-Like Receptor 9 with High Dose CpG ODN 1826 Impairs Endothelial Regeneration and Promotes Atherosclerosis in Mice.
Krogmann AO; Lüsebrink E; Steinmetz M; Asdonk T; Lahrmann C; Lütjohann D; Nickenig G; Zimmer S
PLoS One; 2016; 11(1):e0146326. PubMed ID: 26751387
[TBL] [Abstract][Full Text] [Related]
32. CpG ODN 2102 promotes antibacterial immune responses and enhances vaccine-induced protection in golden pompano (Trachinotusovatus).
Chen X; Wu Y; Qiu Y; Li P; Cao Z; Zhou Y; Sun Y
Fish Shellfish Immunol; 2023 Jun; 137():108783. PubMed ID: 37137380
[TBL] [Abstract][Full Text] [Related]
33. Cutting edge: species-specific TLR9-mediated recognition of CpG and non-CpG phosphorothioate-modified oligonucleotides.
Roberts TL; Sweet MJ; Hume DA; Stacey KJ
J Immunol; 2005 Jan; 174(2):605-8. PubMed ID: 15634876
[TBL] [Abstract][Full Text] [Related]
34. Mannose receptor 1 mediates cellular uptake and endosomal delivery of CpG-motif containing oligodeoxynucleotides.
Moseman AP; Moseman EA; Schworer S; Smirnova I; Volkova T; von Andrian U; Poltorak A
J Immunol; 2013 Dec; 191(11):5615-24. PubMed ID: 24184555
[TBL] [Abstract][Full Text] [Related]
35. Cooperation of Oligodeoxynucleotides and Synthetic Molecules as Enhanced Immune Modulators.
Nigar S; Shimosato T
Front Nutr; 2019; 6():140. PubMed ID: 31508424
[TBL] [Abstract][Full Text] [Related]
36. The immune responses triggered by CpG ODNs in shrimp Litopenaeus vannamei are associated with LvTolls.
Sun R; Wang M; Wang L; Yue F; Yi Q; Huang M; Liu R; Qiu L; Song L
Dev Comp Immunol; 2014 Mar; 43(1):15-22. PubMed ID: 24176974
[TBL] [Abstract][Full Text] [Related]
37. Molecular Bottlebrushes for Immunostimulatory CpG ODN Delivery: Relationship among Cation Density, Complex Formation Ability, and Cytotoxicity.
Takano S; Miyashima Y; Fujii S; Sakurai K
Biomacromolecules; 2023 Mar; 24(3):1299-1309. PubMed ID: 36762890
[TBL] [Abstract][Full Text] [Related]
38. Activation of rabbit TLR9 by different CpG-ODN optimized for mouse and human TLR9.
Liu J; Xu C; Liu YL; Matsuo H; Hsieh RP; Lo JF; Tseng PH; Yuan CJ; Luo Y; Xiang R; Chuang TH
Comp Immunol Microbiol Infect Dis; 2012 Sep; 35(5):443-51. PubMed ID: 22560893
[TBL] [Abstract][Full Text] [Related]
39. Impact of modifications of heterocyclic bases in CpG dinucleotides on their immune-modulatory activity.
Vollmer J; Weeratna RD; Jurk M; Davis HL; Schetter C; Wüllner M; Wader T; Liu M; Kritzler A; Krieg AM
J Leukoc Biol; 2004 Sep; 76(3):585-93. PubMed ID: 15218053
[TBL] [Abstract][Full Text] [Related]
40. Construction of Monomeric and Dimeric G-Quadruplex-Structured CpG Oligodeoxynucleotides for Enhanced Uptake and Activation in TLR9-Positive Macrophages.
Liao W; Tan M; Kusamori K; Takakura Y; Nishikawa M
Nucleic Acid Ther; 2020 Oct; 30(5):299-311. PubMed ID: 32559406
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
